Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults4 Aug 2026

Cholamandalam Investment and Finance Company Ltd

Uploaded Transcript of the Earnings Call

Cholamandalam Investment and Finance Company Ltd reported strong growth in Q1 FY27 with aggregate disbursements increasing 22% YoY to INR29,612 crores, AUM expanding 23% YoY to INR2,54,392 crores, and NIMs improving by 42 bps YoY. The company maintained a strong liquidity and capital position with liquid assets of INR23,984 crores and a capital adequacy ratio of 19.81%. The management expressed confidence in achieving the credit cost guidance of 1.5% for FY27.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Aequs Ltd

Aequs Limited has informed the Exchange about Transcript of Earnings Conference Call held on Wednesday, July 29, 2026, pertaining to the Un-audited Financial Results of the Company for ....

Aequs Ltd's Q1 FY27 earnings conference call transcript reveals a strong start to the year, with consolidated revenue growing 55% YoY to INR3,955 million. The company's consumer segment nearly tripled, and its aerospace segment grew 40% YoY. However, reported EBITDA was lower than Q4 due to other income and foreign exchange. Excluding these factors, EBITDA improved sequentially, driven by narrowing consumer loss.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Sanofi India Ltd

Kindly refer the attachment

Sanofi India Ltd has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to Q2 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Sanofi India Ltd

Kindly refer the attachment

Sanofi India Ltd has announced its Q2 2026 financial results, with domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Birlasoft Ltd

Transcript of Earnings Call held on July 28, 2026

Birlasoft Ltd reported Q1 FY27 earnings with revenue growth of 0.3% in constant currency quarter-on-quarter, but 2.3% in rupee terms, and 7.4% year-on-year. EBITDA margins normalized to 16.1% without one-off items, and cash collections were strong, leading to increased cash balances. The company also signed $168.7 million of TCV signings, up 20% year-on-year, including several AI-led engagements.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Refex Industries Ltd

Transcript of the Earnings Conference Call held for the 1st Quarter ended June 30, 2026 - Q1 FY27

Refex Industries Limited has announced its Q1 FY27 earnings conference call transcript, highlighting a strong operational performance in its ash and coal handling business, driven by robust execution, a healthy order pipeline, and continued progress across strategic growth platforms. The company's integrated approach has enabled a robust nationwide ecosystem for sustainable ash management, making it the most preferred vendor for thermal power plants.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Sanofi India Ltd

Kindly refer the attachment

Sanofi India Ltd announced its financial results for Q2 2026, reporting domestic net sales growth of 8% and total net sales growth of 6% compared to Q2 2025. The Insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by Lantus, Toujeo, and Apidra. Profit before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults4 Aug 2026

Sanofi India Ltd

Kindly refer the attachment

Sanofi India Ltd has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to Q2 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong performance of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27%.

Read more →📎 1 attachment
BSEResult▲ PositiveResults4 Aug 2026

Sanofi India Ltd

Kindly refer the attachment

Sanofi India Ltd reported its unaudited financial results for the quarter and half year ended 30th June 2026, with domestic net sales growth of 8% and total net sales growth of 6% compared to the second quarter of 2025. The company's profits before tax and exceptional items increased 19% to INR 112 crores, with a profit before tax as a percentage of net sales improving to 27% in Q2 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Varun Beverages Ltd

Transcript of Investors & Analysts Conference Call

Varun Beverages Ltd reported a strong performance in Q2 and H1 CY2026, with consolidated sales volume growing by 19.8% and net revenue from operations increasing by 20.4%. The company also extended its exclusive bottling and trademark license agreement with PepsiCo in India until April 2049 and entered a strategic alliance with Asahi Group Holdings to introduce the CALPIS brand in India.

Read more →📎 1 attachment
BSECompany Update▲ PositiveJoint Venture4 Aug 2026

Rashi Peripherals Ltd

Press Release on Proposed Joint Venture with Restar Corporation, Japan, approved by the Board of Directors of the Company at their Meeting held on August 4, 2026.

Rashi Peripherals Ltd has announced a joint venture with Restar Corporation, a Japanese electronics and technology company, to strengthen its semiconductor and embedded solutions business. The joint venture will focus on delivering advanced image sensing solutions for industrial and automotive applications, with a 74% shareholding by Rashi Peripherals and 26% by Restar Corporation.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults4 Aug 2026

Bajaj Housing Finance Ltd

Transcript of Conference Call held on 29 July 2026

Bajaj Housing Finance Ltd reported Q1 FY27 earnings, with AUM growth of 24%, disbursements growth of 33%, and PAT growth of 23% YoY. The company's AUM stood at INR1.496 lakh crores, with home loan growth improving to 20%, LAP growing 22%, LRD growing 41%, and developer finance growing 19%. The company's cost of funds moderated by 7 bps on sequential basis.

Read more →📎 1 attachment
← PreviousPage 357 of 468Next →